BCL9 Antikörper (AA 1119-1328)
Kurzübersicht für BCL9 Antikörper (AA 1119-1328) (ABIN2590096)
Target
Alle BCL9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1119-1328
-
Aufreinigung
- Affinity purified
-
Immunogen
-
Recombinant Bcl9 (Ile1119-Gly1328) expressed in E. coli.
Type of Immunogen: Recombinant protein -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Approved: WB (1:100 - 1:400)
Usage: ELISA 1:100-1:5000, ICC 1:50-500, WB 1:50-400, -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, pH 7.4, 0.02 % sodium azide, 50 % glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Store frozen product at or below -20°C. Thawed product may be stored for 2-4 weeks at 4°C. For optimal storage, aliquot to smaller portions and store at -20°C to -70°C. Avoid freeze-thaw cycles.
-
-
- BCL9 (B-Cell CLL/lymphoma 9 (BCL9))
-
Andere Bezeichnung
- BCL9
-
Hintergrund
-
Name/Gene ID: BCL9
Family: Cancer
Synonyms: BCL9, Bcl-9, B-cell CLL/lymphoma 9, B-cell CLL/lymphoma 9 protein, LGS, Protein legless homolog, B-cell lymphoma 9 protein -
Gen-ID
- 607
-
Pathways
- Stem Cell Maintenance
Target
-